SynthesisVeterinary medicine and science2026
Seroprevalence of Brucellosis Among Camels and Camel Owners in Ethiopia: A Systematic Review and Meta-Analysis (2000-2025).
Synthesis in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review on Major Challenges of Veterinary Service Delivery in Ethiopia.Veterinary medicine and science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCamel brucellosis is a neglected zoonotic disease that poses a significant economic and public health threat, particularly in regions where camel is vital to the pastoral community. Despite being an important health issue, there is limited comprehensive evidence on the burden of brucellosis in camel and camel owners in endemic countries. The objective of this review was to evaluate the prevalence of brucellosis among camels and camel owners in Ethiopia.
methodsThe review sought major databases, including PubMed, ScienceDirect, Scopus, Web of Science and Google Scholar following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocols guidelines, with all searches completed by 30 September 2025. Heterogeneity among studies was assessed and a random-effects model was used to estimate the pooled seroprevalence of brucellosis in camels and their owners. Subgroup analysis, meta-regression and sensitivity analysis were used to identify the sources of variation. Funnel plots, along with Egger's tests, were employed to evaluate publication bias.
resultsThe pooled seroprevalence of brucellosis in camel was found to be 3.0% (95% confidence interval [CI]: 2.0, 4.0), whereas in camel owners it was 14.0% (95% CI: 0.0, 34.0). The subgroup analysis revealed the highest seroprevalence of camel brucellosis was 5.0% (95% CI: 3.0, 6.0) in the Afar region, followed by 3.0% (95% CI: 2.0, 6.0) in Tigray and 2.0% (95% CI: 1.0, 3.0) in the Somali and Oromia regions. Furthermore, the analysis by publication year revealed that the seroprevalence from 2017 to 2025 was higher, at 3.0% (95% CI: 2.0, 4.0), compared to 2000-2016, which had a seroprevalence of 2.0% (95% CI: 1.0, 3.0).
conclusionThis meta-analysis emphasizes that brucellosis in camels and their owners continues to pose a significant threat in Ethiopia. Therefore, it is critical for veterinary and public health sectors to collaborate in designing and implementing effective prevention and control strategies for camel and camel owners' brucellosis using a One Health framework.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.